Document ID: chunk:federal_register_of_legislation:F2019L01093:reg:9:p2
Version: federal_register_of_legislation:F2019L01093
Segment Type: reg
Provision Reference: reg 9 (pt 2/3)
Character Range: 6380–9528

ear of the affected side, at the time of the clinical onset of conductive hearing loss;
            Note: Examples of neoplasms or mass lesions involving the middle ear include, but are not limited to:
              (a)                       cholesteatoma;
              (b)       granuloma; and
              (c)         neuroendocrine adenoma.
(12)      having a disease from the specified list of autoimmune diseases, at the time of the clinical onset of conductive hearing loss;
Note: specified list of autoimmune diseases is defined in the Schedule 1 – Dictionary.
(13)      undergoing a course of therapeutic radiation for cancer, where the conductive hearing apparatus of the affected side was in the field of radiation, before the clinical onset of conductive hearing loss;
Note: conductive hearing apparatus is defined in the Schedule 1 – Dictionary.
(14)      having otosclerosis on the affected side at the time of the clinical worsening of conductive hearing loss;
(15)      having a disease from the specified list of bone diseases, involving the conductive hearing apparatus of the affected side, at the time of the clinical worsening of conductive hearing loss;
Note: conductive hearing apparatus and specified list of bone diseases are defined in the Schedule 1 - Dictionary.
(16)      having osteoporosis at the time of the clinical worsening of conductive  hearing loss;
(17)      having an episode of otitic barotrauma involving the affected ear, within the seven days before the clinical worsening of conductive hearing loss;
(18)      being exposed to a peak sound pressure level at the tympanic membrane of at least 140 dB(C), within the seven days before the clinical worsening of conductive hearing loss;
Note: dB(C) is defined in the Schedule 1 - Dictionary.
(19)      being exposed to an explosive blast within the seven days before the clinical worsening of conductive hearing loss;
(20)      being struck by lightning within the seven days before the clinical worsening of conductive hearing loss;
(21)      having blunt trauma, penetrating trauma or surgery, involving the conductive hearing apparatus of the affected ear, within the seven days before the clinical worsening of conductive hearing loss;
Note: conductive hearing apparatus is defined in the Schedule 1 - Dictionary.
(22)      having acquired, permanent narrowing or obstruction of the external auditory canal of the affected ear, at the time of the clinical worsening of conductive hearing loss;
             Note 1:   Examples of causes of narrowing or obstruction of the external auditory canal include, but are not limited to:
                (a)        benign fibro-osseous lesion;
                (b)       benign or malignant neoplasm;
                (c)        chronic otitis externa;
                (d)       exostosis of the external auditory canal;
                (e)        granuloma; and
                (f)        necrotising otitis externa.
Note 2: exostosis of the external auditory canal is defined in the Schedule 1 – Dictionary.
(23)      having chronic otitis media, involving the middle ear of the affected side, at the time of the